Clover Health Investments, Corp.
CLOV
$2.49
$0.041.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 479.13M | 469.83M | 456.91M | 330.68M | 322.58M |
| Total Other Revenue | 17.52M | 7.79M | 5.43M | 6.28M | 8.41M |
| Total Revenue | 496.65M | 477.62M | 462.33M | 336.96M | 330.99M |
| Cost of Revenue | 423.47M | 377.99M | 353.44M | 243.04M | 249.77M |
| Gross Profit | 73.18M | 99.63M | 108.89M | 93.92M | 81.21M |
| SG&A Expenses | 97.15M | 109.79M | 109.70M | 115.02M | 90.20M |
| Depreciation & Amortization | 406.00K | 394.00K | 466.00K | 344.00K | 339.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 521.03M | 488.18M | 463.61M | 358.41M | 340.31M |
| Operating Income | -24.38M | -10.56M | -1.27M | -21.45M | -9.32M |
| Income Before Tax | -24.38M | -10.58M | -1.27M | -21.48M | -8.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.38M | -10.58M | -1.27M | -21.48M | -8.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -611.00K | -370.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.38M | -10.58M | -1.27M | -22.09M | -9.16M |
| EBIT | -24.38M | -10.56M | -1.27M | -21.45M | -9.32M |
| EBITDA | -23.97M | -10.17M | -808.00K | -21.10M | -8.98M |
| EPS Basic | -0.05 | -0.02 | 0.00 | -0.04 | -0.02 |
| Normalized Basic EPS | -0.03 | -0.01 | 0.00 | -0.03 | -0.01 |
| EPS Diluted | -0.05 | -0.02 | 0.00 | -0.05 | -0.02 |
| Normalized Diluted EPS | -0.03 | -0.01 | 0.00 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 512.74M | 509.04M | 497.06M | 491.87M | 490.18M |
| Average Diluted Shares Outstanding | 512.74M | 509.04M | 497.06M | 491.87M | 490.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |